This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ResMed Launches SleepSeeker Online Tool To Increase Patient Engagement In Therapy For Sleep-Disordered Breathing

BALTIMORE, June 3, 2013 /PRNewswire/ -- (SLEEP 2013 BOOTH #900)  Increasing patient engagement in sleep-disordered breathing therapy has a powerful new asset with ResMed's SleepSeeker online tool, available now. Hosted on WakeUptoSleep.com, ResMed's online patient support community, SleepSeeker was introduced this week at SLEEP 2013, the annual meeting of the Associated Professional Sleep Societies.

(Photo: http://photos.prnewswire.com/prnh/20130603/LA24399)

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

With SleepSeeker, patients using ResMed's S9™ series air flow generators will be able to view their own therapy data just as a doctor might see it, including time used, and any apnea or hypopnea events. They'll also be able to view any present mask leaks. And all this may be done without the need for a Bluetooth adapter because S9 devices are equipped with SD cards from which your PC can upload the data.

Patients using ResMed S9, S8 TM or S7 TM series devices, or who use a therapy device from another manufacturer, may choose to:
  • Follow pre-set plans, or create their own, to monitor progress and achievements in therapy
  • Create and participate in challenges with other users to stay motivated to meet their therapy goals
  • Promote their therapy progress on social media
  • View their data using the SleepSeeker iPhone app, available on the Apple App Store (beginning July 1).  

"We know that patient engagement can be a powerful force in improving compliance," said Susan de la Torre, director, channel marketing for ResMed. "SleepSeeker engages patients by providing encouragement and motivation to learn about their therapy and gives them the tools to become their own health advocates." 

Wake Up to Sleep is a comprehensive online resource for patients and families to learn more about sleep-disordered breathing, how to be diagnosed, treatment options, and tips for successful therapy. SleepSeeker is free to patients and requires registration for a Wake Up to Sleep account.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs